Signe BioPharma Inc was established on June 21, 2005 as a Delaware Corporation with Authorization to Operate in the State of Texas.
Signe BioPharma Inc and Logo became a registered Trademark (USPTO) on May 1, 2007.
A merger with BioTechnology Holdings Partners LP (BTH LP) was completed September 6, 2007. Signe BioPharma acquired all assets of BTH LP, including Intellectual Property originally developed by Dr. David A. Sirbasku. Signe BioPharma Inc is the surviving business entity.
As of January 1, 2008, Signe BioPharma Inc is a privately held corporation with fewer than 10 stockholders.
Signe BioPharma Inc is represented by the corporate law firm of Leggett and Clemons, Plano, Texas. Leggett and Clemons evaluates all business contracts considered by Signe BioPharma Inc.
Signe has retained the Certified Public Accounting (CPA) firm of Whitley Penn LLP, Fort Worth, Texas, to assist in quarterly monitoring the company's finances, preparing financial reports, and preparing and filing Federal Internal Revenue Service and State income/franchise tax returns. Whitley Penn evaluates the financial aspects of contracts considered by Signe BioPharma Inc.
First Offices of Signe BioPharma Inc
WHERE SIGNE STARTED
The building on the left is the first office location of Signe BioPharma Inc in Lewisville, Texas (Suite 301).
The office/warehouse was 600 square feet with no running water, no heat and only limited air conditioning - but the roof was good. (Looks a little like the HP garage).
THE FUTURE - WHERE'S SIGNE GOING?
Signe BioPharma Inc plans to become a Fortune 500 list BioPharmaceutical manufacturing company located in North Texas. Its core business will be the production and sales of therapeutic and other commercially important proteins.
